> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-141/
- Published: 2017-07-23T12:00:00.000Z
- Updated: 2026-09-14T22:35:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139200

[**3 Public Meetings on Drug Distribution**](https://www.fdaweb.com/3-public-meetings-on-drug-distribution/)  
*Federal Register* notice: FDA announces three public meetings entitled “Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act.” 07/21/2017

[**Comments on Unapproved Animal Drugs for Minor Species Listing**](https://www.fdaweb.com/comments-on-unapproved-animal-drugs-for-minor-species-listing/)  
*Federal Register* notice: FDA seeks comments on an information collection extension on its “Index of Legally Marketed Unapproved New Animal Drugs for Minor Species — 21 CFR part 516.” 07/21/2017

[**Comments Sought on Animal Drug Fee Cover Sheet**](https://www.fdaweb.com/comments-sought-on-animal-drug-fee-cover-sheet/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Animal Drug User Fee Cover Sheet.” 07/20/2017

[**Public Meeting on Hereditary Angioedema Drug Development**](https://www.fdaweb.com/public-meeting-on-hereditary-angioedema-drug-development/)  
*Federal Register* notice: FDA announces a 9/25 public meeting on “Patient-Focused Drug Development for Hereditary Angioedema.” 07/20/2017

[**Pilot Program on Pharmaceutical Supply Chain Security**](https://www.fdaweb.com/pilot-program-on-pharmaceutical-supply-chain-security/)  
*Federal Register* notice: FDA announces a pilot project program under the Drug Supply Chain Security Act to assist in developing an electronic, interoperable system that will identify and trace certain prescription drugs as they are distributed within the U.S. 07/20/2017

[**Comments Sought on Animal Drug User Fee Waivers**](https://www.fdaweb.com/comments-sought-on-animal-drug-user-fee-waivers/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for a guidance on “Animal Drug User Fees and Fee Waivers and Reductions.” 07/20/2017

[**Comments Sought on ICH Clinical Practice Guide**](https://www.fdaweb.com/comments-sought-on-ich-clinical-practice-guide/)  
*Federal Register* notice: FDA seeks comments on a new information collection associated with “Guidance on E6 (R2) Good Clinical Practice; International Council for Harmonization (ICH)” that amends an ICH guidance entitled ‘‘E6 Good Clinical Practice: Consolidated Guidance’’ (issued in 1996). 07/19/2017

[**Comments Sought on DTC Studies**](https://www.fdaweb.com/comments-sought-on-dtc-studies/)  
*Federal Register* notice: FDA seeks comments on proposed studies on “Character Space-Limited Online Prescription Drug Communications.” 07/19/2017

[**Comments Sought on Biologic Adverse Event Reporting**](https://www.fdaweb.com/comments-sought-on-biologic-adverse-event-reporting/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Adverse Experience Reporting for Licensed Biological Products; and General Records — 21 CFR Part 600.” 07/18/2017

[**Comments Sought on Combination Product Guidance**](https://www.fdaweb.com/comments-sought-on-combination-product-guidance/)  
*Federal Register* notice: FDA seeks comments on a new information collection related to a “Draft Guidance for Industry — How To Prepare a Pre-Request for Designation” that outlines requests for feedback from the Office of Combination Products on whether a medical product will be regulated as a drug, a device, a biologic, or a combination product. 07/18/2017